Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Trial Phases

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

Here is a helpful link from the American Cancer Society that explains the differences between Phase I, II, III and IV trials.

While the party line is that Phase I trials are only about dose and safety, don’t believe for a second that the researchers and the patients in the trials are not hoping for a strong signal that they have an active drug in the clinic.

Phase III trials are usually where there are at least two different randomized arms to compare the value of the novel therapy against the usual standard of care, and ultimately get FDA approval.

RECENT NEWS

When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.